Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.395
Delayed Data
As of Aug 28
 +0.005 / +1.28%
Today’s Change
0.34
Today|||52-Week Range
3.98
-75.31%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.39
Today’s open0.39
Day’s range0.39 - 0.42
Volume775,353
Average volume (3 months)1,577,494
Market cap$25.3M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+72.78%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book7.35

Competitors

 Today’s
change
Today’s
% change
GENEGenetic Technologies...+0.16+7.48%
ENUMEnumeral Biomedical ...+0.01+1.74%
RGBPRegen BioPharma Inc-0.00-2.13%
--Cell Source Inc0.000.00%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts

Partner Offers